Correction to “Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)” [The Lancet Regional Health – Europe 41 (2024) 100915]
Pascal Demoly,
Mathieu Molimard,
Jean-François Bergmann,
Bertrand Delaisi,
Amandine Gouverneur,
Jade Vadel,
Cédric Collin,
Laurence Girard,
Silvia Scurati,
Philippe Devillier
Affiliations
Pascal Demoly
University Hospital of Montpellier and IDESP, University of Montpellier – INSERM – INRIA PreMediCal, Montpellier, France; Corresponding author.
Mathieu Molimard
Department of Medical Pharmacology, Bordeaux University, Bordeaux, France
Jean-François Bergmann
Department of Internal Medicine, Lariboisière Hospital, AP-HP, Université Paris-Cité, Paris, France
Bertrand Delaisi
Institut de l’Enfant, Clinique Marcel Sembat, Boulogne Billancourt, France
Amandine Gouverneur
IQVIA, RWS, France
Jade Vadel
IQVIA, RWS, France
Cédric Collin
IQVIA, RWS, France
Laurence Girard
Stallergenes Greer, France
Silvia Scurati
Stallergenes Greer, France
Philippe Devillier
VIM Suresnes – UMR_0892 & Clinical Research Unit, Airway Diseases Department, Foch Hospital, University Versailles Saint-Quentin, Suresnes, France
